The primary objective of this study will be the collection of preliminary clinical evidence to indicate that Cast21 Short Arm Product is no worse than the current standard of care arm immobilization devices in pediatric patients. A secondary objective will be to characterize the clinician and patient experience with the Cast21 Short Arm Product.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical determination of healing (standard of care)
Timeframe: At treatment completion, an average of 4 weeks
Range of Motion (standard of care)
Timeframe: At treatment completion, an average of 4 weeks